Transoral Robotic Surgery (TORS); A More Conservative Approach to Posterior Tongue Carcinomas, and a Better Quality of Life Post-Operatively

Introduction: Transoral robotic surgery (TORS) first gained US FDA approval in 2009, for the resection of oropharyngeal cancers. It has since been used widely in this respect, and is seen as a conservative or minimally-invasive approach to head and neck surgery, while also being linked with significantly lower use of adjuvant chemoradiation1. (Source: The British Journal of Oral and Maxillofacial Surgery)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Bs2aRM